BWBowen Wu

Bowen Wu

*This is an algorithmically generated author record based on publicly available information.

Bowen Wu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • An Ma

    School of Basic Medical Sciences & Forensic Medicine, Hangzhou Medical College, Zhejiang, China

    2 shared publications
  • Yichao Gan

    Institute of Genetics

    2 shared publications
  • Yingwan Luo

    Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

    2 shared publications
  • Choe Kyong Ho

    Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; College of International Education, Zhejiang University, Hangzhou 310058, China; Haeju Medical University, Haeju, Democratic People's Republic of Korea

    1 shared publication
  • Dan-Yan Zhu

    Institute of Pharmacology and Toxicology, Zhejiang University, Hangzhou, China

    1 shared publication
  • Hao Yu

    Chinese Medicine Guangdong Laboratory (Hengqin Laboratory), Guangdong-Macao In-Depth Cooperation Zone in Hengqin, Zhuhai, China

    1 shared publication

Latest Publications

  • Open Access

    DAP10 Predicted the Outcome of Pediatric B-Cell Acute Lymphoblastic Leukemia and Was Associated with the T-Cell Exhaustion

    by Nana Shi, Yingwan Luo, Ying Xu, Junyu Liang, An Ma, Yichao Gan, Bowen Wu

    B-cell acute lymphoblastic leukemia is the most common malignant tumor in children. About 10–15% of patients will relapse with a 5-year OS of 57.5% for the past 20 years. As tumor microenvironment plays an important role in the disease process, many types of immunotherapy are approached. New immunotherapies including CAR-T cells have been developed for refractory B-ALL treatment. However, CAR-T treatment faces several problems, including loss of the target antigen and in vivo T-cell persistence. Here, we analyzed the tumor microenvironment of pediatric B-ALL patients in TARGET database. Using Cox analysis and PPI network, we finally sorted out the DAP10 gene. We found that DAP10 was hardly expressed in leukemic B cells. DAP10 was downregulated in B-ALL compared with normal individuals, and low expression level of DAP10 predicted poor survival. Furthermore, we found the tumor microenvironment was different in DAP10 high and low expression children. The CD8+ T cells might be hard to activate and more likely to suffer from exhaustion in DAP10 lowly expressed children. In conclusion, our results showed that DAP10 was a well biomarker to indicate the prognosis and tumor microenvironment in pediatric B-ALL. The treatment strategy of immunotherapy for the leukemic children with DAP10 lowly expressed should be adjusted if needed.


  • Open Access

    The diagnostic and prognostic value of cell division cycle associated gene family in Hepatocellular Carcinoma

    by Bowen Wu, Yu Huang, Yingwan Luo, An Ma, Zhaoxing Wu, Yichao Gan, Ying Xu, Rongzhen Xu

    Cell division cycle associated (CDCA) gene family plays an important role in cells. However, some researchers revealed that overexpression of CDCAs might contribute to the tumor progression in several cancers. Here, we analyzed the role of this gene family in hepatocellular carcinoma (HCC). We used several web tools and found that most of CDCAs were highly expressed in tumor tissues compared to the paracancer tissues in HCC. We then used RT-qPCR to confirm our results. The results showed that CDCA2, CDCA3, CDCA5 and CDCA8 were up-regulated in HCC. We also found that these genes were associated with poor overall survival and relapse free survival except CDCA7. The functional analysis showed that this gene family might take part in many processes, including cell division, apoptosis, DNA damage and DNA repair, which might contribute to the tumor progression. The KEGG pathway analysis showed that these genes participated in several important pathways such as PI3K-Akt signaling pathway and hippo signaling pathway. In conclusion, our findings suggested that CDCA2, CDCA3, CDCA4, CDCA5, and CDCA8 might have potential diagnostic and prognostic values for hepatocellular carcinoma.


  • Peroxiredoxin-2 nitrosylation facilitates cardiomyogenesis of mouse embryonic stem cells via XBP-1s/PI3K pathway

    by Bowen Wu, Hao Yu, Yifan Wang, Zongfu Pan, Yihan Zhang, Tong Li, Lu Li, Weichen Zhang, Lijun Ge, Ying Chen, et al.